Literature DB >> 16773471

Citrulline and ammonia accumulating in citrullinemia reduces antioxidant capacity of rat brain in vitro.

Cristina C Prestes1, Angela M Sgaravatti, Carolina D Pederzolli, Mirian B Sgarbi, Giovanni K Zorzi, Clóvis M D Wannmacher, Moacir Wajner, Angela T S Wyse, Carlos Severo Dutra Filho.   

Abstract

Citrullinemia is an inborn error of the urea cycle caused by deficient argininosuccinate synthetase, which leads to accumulation of L-citrulline and ammonia in tissues and body fluids. The main symptoms include convulsions, tremor, seizures, coma, and brain edema. The pathophysiology of the neurological signs of citrullinemia remains unclear. In this context, we investigated the in vitro effects of L-citrulline and ammonia in cerebral cortex from 30-day-old rats on oxidative stress parameters, namely thiobarbituric acid-reactive substances (TBA-RS), chemiluminescence, mitochondrial membrane protein thiol content, intracellular content of hydrogen peroxide, total radical-trapping antioxidant potential (TRAP), total antioxidant reactivity (TAR) as well as on the activities of the antioxidant enzymes (catalase, superoxide dismutase, and glutathione peroxidase). L-Citrulline significantly diminished TRAP (26%) and TAR (37%), while ammonia decreased TAR (30%). Ammonia increased SOD activity (65%) and L-citrulline did not affect the activities of any antioxidant enzymes. We also observed that L-citrulline and ammonia did not alter lipid peroxidation parameters, levels of hydrogen peroxide, and mitochondrial membrane protein thiol content. Taken together, these results may indicate that L-citrulline and ammonia decreased the antioxidant capacity of the brain, which may reflect a possible involvement of oxidative stress in the neuropathology of citrullinemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16773471     DOI: 10.1007/s11011-006-9005-6

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  27 in total

1.  Pathogenesis of adult-onset type II citrullinemia caused by deficiency of citrin, a mitochondrial solute carrier protein: tissue and subcellular localization of citrin.

Authors:  M Iijima; A Jalil; L Begum; T Yasuda; N Yamaguchi; M Xian Li; N Kawada; H Endou; K Kobayashi; T Saheki
Journal:  Adv Enzyme Regul       Date:  2001

2.  Mitochondrial membrane protein thiol reactivity with N-ethylmaleimide or mersalyl is modified by Ca2+: correlation with mitochondrial permeability transition.

Authors:  A J Kowaltowski; A E Vercesi; R F Castilho
Journal:  Biochim Biophys Acta       Date:  1997-02-15

Review 3.  Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment.

Authors:  B Halliwell
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

4.  Glutathione peroxidase.

Authors:  A Wendel
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

Review 5.  Glutamate uptake.

Authors:  N C Danbolt
Journal:  Prog Neurobiol       Date:  2001-09       Impact factor: 11.685

6.  EEG changes during recovery from acute severe neonatal citrullinemia.

Authors:  R R Clancy; H J Chung
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1991-03

7.  Glutamate and gamma-aminobutyric acid neurotransmitter systems in the acute phase of maple syrup urine disease and citrullinemia encephalopathies in newborn calves.

Authors:  P R Dodd; S H Williams; A L Gundlach; P A Harper; P J Healy; J A Dennis; G A Johnston
Journal:  J Neurochem       Date:  1992-08       Impact factor: 5.372

8.  Characterization of 2',7'-dichlorofluorescin fluorescence in dissociated mammalian brain neurons: estimation on intracellular content of hydrogen peroxide.

Authors:  Y Oyama; A Hayashi; T Ueha; K Maekawa
Journal:  Brain Res       Date:  1994-01-28       Impact factor: 3.252

9.  Nature and frequency of mutations in the argininosuccinate synthetase gene that cause classical citrullinemia.

Authors:  K Kobayashi; H Kakinoki; T Fukushige; N Shaheen; H Terazono; T Saheki
Journal:  Hum Genet       Date:  1995-10       Impact factor: 4.132

10.  Sources of oxygen radicals in brain in acute ammonia intoxication in vivo.

Authors:  Elena Kosenko; Natalia Venediktova; Yury Kaminsky; Carmina Montoliu; Vicente Felipo
Journal:  Brain Res       Date:  2003-08-15       Impact factor: 3.252

View more
  6 in total

1.  Two hypomorphic alleles of mouse Ass1 as a new animal model of citrullinemia type I and other hyperammonemic syndromes.

Authors:  Carlos J Perez; Jean Jaubert; Jean-Louis Guénet; Kirstin F Barnhart; Catherine M Ross-Inta; Vicente C Quintanilla; Isabelle Aubin; Jimi L Brandon; Nancy W Otto; John DiGiovanni; Irma Gimenez-Conti; Cecilia Giulivi; Donna F Kusewitt; Claudio J Conti; Fernando Benavides
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

2.  Moderate grade hyperammonemia induced concordant activation of antioxidant enzymes is associated with prevention of oxidative stress in the brain slices.

Authors:  Aditi Mehrotra; Surendra Kumar Trigun
Journal:  Neurochem Res       Date:  2011-09-16       Impact factor: 3.996

3.  Protective effect of resveratrol on citrullinemia type I-induced brain oxidative damage in male rats.

Authors:  Larissa Delmonego; Thayná Patachini Maia; Débora Delwing-Dal Magro; Karine Louize Vincenzi; Aline Barbosa Lima; Luana Carla Pscheidt; Letícia Eger; Daniela Delwing-de Lima
Journal:  Metab Brain Dis       Date:  2021-02-08       Impact factor: 3.584

4.  Profiling of oxidative stress in patients with inborn errors of metabolism.

Authors:  Peter J Mc Guire; Aditya Parikh; George A Diaz
Journal:  Mol Genet Metab       Date:  2009-06-14       Impact factor: 4.797

5.  Effects of resveratrol on alterations in cerebrum energy metabolism caused by metabolites accumulated in type I citrullinemia in rats.

Authors:  Karine Louize Vincenzi; Thayna Patachini Maia; Larissa Delmônego; Aline Barbosa Lima; Luana Carla Pscheidt; Débora Delwing-Dal Magro; Daniela Delwing-de Lima
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-11-18       Impact factor: 3.000

6.  Magnetic resonance imaging findings and neurodevelopmental outcomes in neonates with urea-cycle defects.

Authors:  Anna Catherine Gunz; Karen Choong; Murray Potter; Elka Miller
Journal:  Int Med Case Rep J       Date:  2013-08-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.